Blood Panel Affirms NAT Superiority With Vote On Proposed Algorithms
This article was originally published in The Gray Sheet
Executive Summary
Nucleic acid testing should be regarded as more reliable than serological tests in the design of HCV (hepatitis C virus) and HIV blood donation re-entry algorithms, FDA's Blood Panel Advisory Committee agreed June 14 in Gaithersburg, Maryland